Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Umeå researchers uncover new ALS gene

17.12.2007
The ALS research team at Umeå University in Sweden, working with Dutch and Belgian colleagues, has found new connections between mutations in gene DPP6 and contracting the non-hereditary form of ALS. The findings are being published in this Sunday's edition of Nature Genetics on the Web.

To try to identify pathological genes that are involved in ALS, the research group at Umeå University, in collaboration with Dutch and Belgian scientists, compared DNA samples from 1,767 patients with non-familial ALS (so-called sporadic ALS, SALS) with DNA samples from 1,916 control individuals. This is the world's most comprehensive ALS study so far. They looked for DNA mutations that only exist in ALS patients, not in controls. After very extensive analyses they found that a DNA mutation in the gene DPP6 strongly correlates with SALS.

The DPP6 gene is on chromosome number 7 and codes for a protein enzyme, a peptidase that regulates the activity of so-called neuropeptides, that is, substances that affect nerve cells. DPP6 is therefore highly interesting as a candidate gene for ALS. Studies are now concentrating on finding disease-associated mutations in the gene. Just how mutations in the DPP6 gene can lead to ALS is unknown today. At present it is not possible to judge whether the discovery will lead to any new treatment for ALS.

The Swedish component of the study was carried out by Associate Professor Peter M. Andersen, molecular geneticist Anna Birve, and research engineer Ann-Charloth Nilsson, all with the Department of Pharmacology and Clinical Neuroscience, Umeå University.

... more about:
»DNA »DPP6 »Umeå

Extensive research on ALS has been pursued at Umeå University since 1992. The objective is to use new knowledge about the mechanisms behind the disease in order to develop therapies for ALS. The main focus is on molecular biological and genetic aspects of the disease and mutations in SOD1 and other genes. Resources (funding, staffing) do not allow any attempted treatment of patients at present.

The research team at Umeå consists of 23 people in four subgroups, directed by Associate Professor Peter Andersen (genetic research), Associate Professor Thomas Brännström (neuropathology), Professor Stefan Marklund (free radicals and cell research), and Associate Professor Henrik Antti (metabolomics).

Contacts:
Anna Birve, post-doctoral fellow, at phone: +46 (0)90-785 29 47 or e-mail: anna.birve@neuro.umu.se.
Associate Professor Peter M. Andersen, phone: +46 (0)90-785 00 00 (exchange,
please page) or e-mail: peter.andersen@neuro.umu.se.
References: Michael A van Es, Paul WJ van Vught, Hylke M Blauw, Lude
Franke, Christiaan GJ Saris, Ludo Van Den Bosch, Sonja W de Jong,
Vianney de Jong, Frank Baas, Ruben van 't Slot, Robin Lemmens,
Helenius J Schelhaas, Anna Birve, Kristel Sleegers, Christine Van
Broeckhoven, Jennifer C Schymick, Bryan J Traynor, John HJ Wokke,
Cisca Wijmenga, Wim Robberecht, Peter M Andersen, Jan H Veldink, Roel
A Ophoff, & Leonard H. van den Berg:
Genetic variation in DPP6 is associated with susceptibility to
amyotrophic lateral sclerosis
Facts about ALS
The cause of the disease is unknown, but c. 10-12% of cases involve one of several hereditary variants of the disorder. In Sweden 200-220 people contract the illness each year. People of various ages are afflicted. The most common age is 50-70 years. Twice as many men as women suffer from the disorder.

The average survival time is 2.5-3 years, but some few patients live >10 years with the disease. There is no curative treatment. As of 1996 there is a medicine that slows down the course of the disease and can extend survival by a few months.

The effect is greatest if the medicine is introduced at an early stage of the illness. Nowadays there are special ALS teams that work to provide patients and their loved ones with the best possible help.

Bertil Born | idw
Further information:
http://www.nature.com/ng/index.html
http://www.umu.se/medfak/forskning/popvet/ALS.html

Further reports about: DNA DPP6 Umeå

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>